Pulmozyme

Product manufactured by Genentech, Inc.

Application Nr Approved Date Route Status External Links
BLA103532 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pulmozyme ® (Dornase Alfa) Is Indicated For Daily Administration In Conjunction With Standard Therapies For The Management Of Cystic Fibrosis (Cf) Patients To Improve Pulmonary Function. In Cf Patients With An Fvc ≥ 40% Of Predicted, Daily Administration Of Pulmozyme Has Also Been Shown To Reduce The Risk Of Respiratory Tract Infections Requiring Parenteral Antibiotics. Pulmozyme Is A Recombinant Dnase Enzyme Indicated In Conjunction With Standard Therapies For The Management Of Cystic Fibrosis (Cf) Patients To Improve Pulmonary Function. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dornase Alfa

Comments